Comparison of the ELISA reactivity of <i>r</i>CatL, Peptide-1, SLbA and the EIE-LVC kit against sera from TL and VL patients and from <i>L. infantum</i>-infected dogs.

<p><b>TL and VL</b>: ELISAs were performed on samples from different groups of individuals (CT, control group; CD, Chagas disease patients; CL, cutaneous leishmaniasis; ML, mucosal leishmaniasis; VL, visceral leishmaniasis). <b>CVL</b>: ELISAs were performed on samples from different groups of dogs (CT, control group; CD, <i>T. cruzi</i>-infected dogs; CVL, canine visceral leishmaniasis). ^*Cut-off obtained by a ROC curve. ^#Cut-off suggested by the manufacturer.